pentobarbital will decrease the extent or impact of ramelteon by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unknown. pentobarbital decreases amounts of panobinostat by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Robust CYP3A4 inducers